Sign in
4

Changes in Ownership

Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-19-029852

Chief Commercial Officer bought 1,000 shares at $7.23 ($7,227)

From the SEC's structured data for this filing

Trades in this filing

Millian Craig Stuart · Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2019-05-14 Purchase : show line 1 in the form +1,000 $7.23 $7,227 6,000 D
Open-market purchases · 1,000 sh · avg $7.23 · $7,227
Loading xslF345X03/doc4.xml…